相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Claudins and Gastric Cancer: An Overview
Itaru Hashimoto et al.
CANCERS (2022)
Molecular mechanism of therapeutic approaches for human gastric cancer stem cells
Hsi-Lung Hsieh et al.
WORLD JOURNAL OF STEM CELLS (2022)
siRNA-mediated silencing of Nanog reduces stemness properties and increases the sensitivity of HepG2 cells to cisplatin
Hajar Alemohammad et al.
GENE (2022)
Nanog suppression enhanced the chemosensitivity of human non-small-cell lung cancer cells to Cisplatin and inhibited cell migration
Basira Najafzadeh et al.
PATHOLOGY RESEARCH AND PRACTICE (2022)
The oncogenic potential of NANOG: An important cancer induction mediator
Basira Najafzadeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
NANOG gene suppression and replacement of let-7 modulate the stemness, invasion, and apoptosis in breast cancer
Zeynab Aliyari Serej et al.
GENE (2021)
Suppression of Nanog inhibited cell migration and increased the sensitivity of colorectal cancer cells to 5-fluorouracil
Neda Khosravi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Pluripotency transcription factor Nanog and its association with overall oral squamous cell carcinoma progression, cisplatin-resistance, invasion and stemness acquisition
Tanushree Kashyap et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2020)
Gastric cancer: a comprehensive review of current and future treatment strategies
Rachel E. Sexton et al.
CANCER AND METASTASIS REVIEWS (2020)
NANOG as prognostic factor of prostate cancer course
T.V. Zadvornyi et al.
Experimental Oncology (2020)
Relation between Immune cell response and stemness genes expression in breast cancer; A new approach in NANOG gene and Let7-a expression in breast cancer cell lines
Zeynab Aliyari-Serej et al.
IMMUNOPATHOLOGIA PERSA (2020)
New insight into NANOG: A novel therapeutic target for ovarian cancer (OC)
Iyer Mahalaxmi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Gastric cancer: epidemiology, prevention, classification, and treatment
Robert Sitarz et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Breast Cancer Spheroids Reveal a Differential Cancer Stem Cell Response to Chemotherapeutic Treatment
Daniel S. Reynolds et al.
SCIENTIFIC REPORTS (2017)
Reduction of NANOG Mediates the Inhibitory Effect of Aspirin on Tumor Growth and Stemness in Colorectal Cancer
Hefei Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy
Adam C. Palmer et al.
CELL (2017)
The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells
Natalia Gawlik-Rzemieniewska et al.
CANCER BIOLOGY & THERAPY (2016)
Silencing expression of the NANOG gene and changes in migration and metastasis of urinary bladder cancer cells
Natalia Gawlik-Rzemieniewska et al.
ARCHIVES OF MEDICAL SCIENCE (2016)
NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer
Suqing Liu et al.
TUMOR BIOLOGY (2016)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Enhanced Chemosensitivity by Targeting Nanog in Head and Neck Squamous Cell Carcinomas
Chuan-En Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Knockdown of NANOG enhances chemosensitivity of liver cancer cells to doxorubicin by reducing MDR1 expression
Jia-Jia Zhou et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis
X. Lu et al.
ONCOGENE (2014)
NANOG promotes liver cancer cell invasion by inducing epithelial-mesenchymal transition through NODAL/SMAD3 signaling pathway
Chun Sun et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers
M. K. Y. Siu et al.
ONCOGENE (2013)
Nanog, a novel prognostic marker for lung cancer
Yaming Du et al.
SURGICAL ONCOLOGY-OXFORD (2013)
Increased Nanog Expression Promotes Tumor Development and Cisplatin Resistance in Human Esophageal Cancer Cells
Li Yang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2012)
Nanog siRNA plus Cisplatin may enhance the sensitivity of chemotherapy in esophageal cancer
Yaming Du et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Overexpression of Nanog protein is associated with poor prognosis in gastric adenocarcinoma
Ting Lin et al.
MEDICAL ONCOLOGY (2012)
Overexpression of nanog predicts tumor progression and poor prognosis in colorectal cancer
Hui-Min Meng et al.
CANCER BIOLOGY & THERAPY (2010)
The human pluripotency gene NANOG/NANOGP8 is expressed in gastric cancer and associated with tumor development
Jingyu Zhang et al.
ONCOLOGY LETTERS (2010)
Cancer therapy through control of cell migration
EG Levin
CURRENT CANCER DRUG TARGETS (2005)
分享论文
